GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (OTCPK:SBLOF) » Definitions » Shiller PE Ratio

Shin Nippon Biomedical Laboratories (Shin Nippon Biomedical Laboratories) Shiller PE Ratio : 29.77 (As of Jun. 08, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Shiller PE Ratio?

As of today (2024-06-08), Shin Nippon Biomedical Laboratories's current share price is $16.97. Shin Nippon Biomedical Laboratories's E10 for the quarter that ended in Dec. 2023 was $0.57. Shin Nippon Biomedical Laboratories's Shiller PE Ratio for today is 29.77.

The historical rank and industry rank for Shin Nippon Biomedical Laboratories's Shiller PE Ratio or its related term are showing as below:

SBLOF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 22.85   Med: 65.68   Max: 442.68
Current: 23.85

During the past years, Shin Nippon Biomedical Laboratories's highest Shiller PE Ratio was 442.68. The lowest was 22.85. And the median was 65.68.

SBLOF's Shiller PE Ratio is ranked better than
55% of 80 companies
in the Medical Diagnostics & Research industry
Industry Median: 28.065 vs SBLOF: 23.85

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shin Nippon Biomedical Laboratories's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.138. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.57 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shin Nippon Biomedical Laboratories Shiller PE Ratio Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories Shiller PE Ratio Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 70.37 63.44 -

Shin Nippon Biomedical Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.44 44.51 34.60 29.83 -

Competitive Comparison of Shin Nippon Biomedical Laboratories's Shiller PE Ratio

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Shiller PE Ratio falls into.



Shin Nippon Biomedical Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shin Nippon Biomedical Laboratories's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=16.97/0.57
=29.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Shin Nippon Biomedical Laboratories's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.138/106.8000*106.8000
=0.138

Current CPI (Dec. 2023) = 106.8000.

Shin Nippon Biomedical Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.085 95.700 0.095
201406 -0.145 98.000 -0.158
201409 0.040 98.500 0.043
201412 -0.001 97.900 -0.001
201503 -0.130 97.900 -0.142
201506 0.469 98.400 0.509
201509 -0.275 98.500 -0.298
201512 0.342 98.100 0.372
201603 -0.008 97.900 -0.009
201606 -0.420 98.100 -0.457
201609 -0.263 98.000 -0.287
201612 0.230 98.400 0.250
201703 0.185 98.100 0.201
201706 -0.131 98.500 -0.142
201709 -0.227 98.800 -0.245
201712 -0.062 99.400 -0.067
201803 -0.366 99.200 -0.394
201806 0.084 99.200 0.090
201809 0.113 99.900 0.121
201812 0.140 99.700 0.150
201903 0.083 99.700 0.089
201906 -0.009 99.800 -0.010
201909 0.205 100.100 0.219
201912 0.160 100.500 0.170
202003 0.211 100.300 0.225
202006 0.144 99.900 0.154
202009 0.113 99.900 0.121
202012 0.078 99.300 0.084
202103 0.483 99.900 0.516
202106 0.398 99.500 0.427
202109 0.366 100.100 0.390
202112 0.368 100.100 0.393
202203 0.381 101.100 0.402
202206 0.349 101.800 0.366
202209 0.415 103.100 0.430
202212 -0.012 104.100 -0.012
202303 0.307 104.400 0.314
202306 0.233 105.200 0.237
202309 0.259 106.200 0.260
202312 0.138 106.800 0.138

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shin Nippon Biomedical Laboratories  (OTCPK:SBLOF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Shin Nippon Biomedical Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shin Nippon Biomedical Laboratories (Shin Nippon Biomedical Laboratories) Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (Shin Nippon Biomedical Laboratories) Headlines